Gastro Flashcards
The ‘double duct’ sign may be seen in –
The ‘double duct’ sign may be seen in pancreatic cancer
Avoid – in bowel obstruction
Avoid metoclopramide in bowel obstruction
A combination of liver and neurological disease points towards –
A combination of liver and neurological disease points towards Wilson’s disease
Proton pump inhibitors should be stopped – before an upper GI endoscopy
Proton pump inhibitors should be stopped 2 weeks before an upper GI endoscopy
In an acute upper GI bleed, the — score can identify low risk patients who may be discharged
In an acute upper GI bleed, the Blatchford score can identify low risk patients who may be discharged
Management of non-variceal bleeding
NICE do not recommend the use of — before endoscopy to patients with suspected non-variceal upper gastrointestinal bleeding although – should be given to patients with non-variceal upper gastrointestinal bleeding and stigmata of recent haemorrhage shown at endoscopy
if further bleeding then options include repeat endoscopy, interventional radiology and surgery
Management of variceal bleeding
- – and prophylactic — should be given to patients at presentation (i.e. before endoscopy)
- – should be used for oesophageal varices and injections of N-butyl-2-cyanoacrylate for patients with gastric varices
- – shunts should be offered if bleeding from varices is not controlled with the above measures
Management of non-variceal bleeding
NICE do not recommend the use of proton pump inhibitors (PPIs) before endoscopy to patients with suspected non-variceal upper gastrointestinal bleeding although PPIs should be given to patients with non-variceal upper gastrointestinal bleeding and stigmata of recent haemorrhage shown at endoscopy
if further bleeding then options include repeat endoscopy, interventional radiology and surgery
Management of variceal bleeding
terlipressin and prophylactic antibiotics should be given to patients at presentation (i.e. before endoscopy)
band ligation should be used for oesophageal varices and injections of N-butyl-2-cyanoacrylate for patients with gastric varices
transjugular intrahepatic portosystemic shunts (TIPS) should be offered if bleeding from varices is not controlled with the above measures
A transjugular intrahepatic portosystemic shunt (TIPS) procedure connects the – vein to the – vein
A transjugular intrahepatic portosystemic shunt (TIPS) procedure connects the hepatic vein to the portal vein
Intestinal angina (or chronic mesenteric ischaemia) is classically characterised by a triad of –+–+– abdominal pain, —, and an – bruit - by far the most common cause is atherosclerotic disease in arteries supplying the GI tract
Intestinal angina (or chronic mesenteric ischaemia) is classically characterised by a triad of severe, colicky post-prandial abdominal pain, weight loss, and an abdominal bruit - by far the most common cause is atherosclerotic disease in arteries supplying the GI tract
Common features in bowel ischaemia
Common predisposing factors
increasing –
— particularly for mesenteric ischaemia
other causes of emboli: endocarditis, malignancy
cardiovascular disease risk factors: smoking, hypertension, diabetes
–: ischaemic colitis is sometimes seen in young patients following — use
Common features
abdominal pain - in acute mesenteric ischaemia this is often of sudden onset, severe and out-of-keeping with physical exam findings
rectal bleeding
diarrhoea
fever
bloods typically show an elevated white blood cell count associated with a lactic acidosis
Diagnosis
—is the investigation of choice
Common features in bowel ischaemia
Common predisposing factors
increasing age
atrial fibrillation - particularly for mesenteric ischaemia
other causes of emboli: endocarditis, malignancy
cardiovascular disease risk factors: smoking, hypertension, diabetes
cocaine: ischaemic colitis is sometimes seen in young patients following cocaine use
Common features
abdominal pain - in acute mesenteric ischaemia this is often of sudden onset, severe and out-of-keeping with physical exam findings
rectal bleeding
diarrhoea
fever
bloods typically show an elevated white blood cell count associated with a lactic acidosis
Diagnosis
CT is the investigation of choice
Large-volume paracentesis for the treatment of ascites requires — ‘cover’. Evidence suggests this reduces paracentesis-induced — and mortality
Large-volume paracentesis for the treatment of ascites requires albumin ‘cover’. Evidence suggests this reduces paracentesis-induced circulatory dysfunction and mortality
– is a key step in the initial management of dyspepsia
Medications that can cause dyspepsia include x3
Reviewing medications is a key step in the initial management of dyspepsia
Medications that can cause dyspepsia include beta-blockers, calcium channel blockers and NSAIDs, for example.
Dyspepsia
The 2015 NICE guidelines ‘Suspected cancer: recognition and referral’ further updated the advice on who needs urgent referral for an endoscopy (i.e. within 2 weeks).
Urgent
All patients who’ve got —
All patients who’ve got an —consistent with stomach cancer
Patients aged >= – years who’ve got weight loss, AND any of the following:
upper abdominal –
–
—
Non-urgent
Patients with –
Patients aged >= – years who’ve got:
treatment-resistant – or
upper abdominal pain with low — levels or
raised – count with any of the following: nausea, vomiting, weight loss, reflux, dyspepsia, upper abdominal pain
nausea or vomiting with any of the following: weight loss, reflux, dyspepsia, upper abdominal pain
Dyspepsia
The 2015 NICE guidelines ‘Suspected cancer: recognition and referral’ further updated the advice on who needs urgent referral for an endoscopy (i.e. within 2 weeks). The list below combines the advice for oesophageal and stomach cancer, with the bold added by the author, not NICE.
Urgent
All patients who’ve got dysphagia
All patients who’ve got an upper abdominal mass consistent with stomach cancer
Patients aged >= 55 years who’ve got weight loss, AND any of the following:
upper abdominal pain
reflux
dyspepsia
Non-urgent
Patients with haematemesis
Patients aged >= 55 years who’ve got:
treatment-resistant dyspepsia or
upper abdominal pain with low haemoglobin levels or
raised platelet count with any of the following: nausea, vomiting, weight loss, reflux, dyspepsia, upper abdominal pain
nausea or vomiting with any of the following: weight loss, reflux, dyspepsia, upper abdominal pain
— should be stopped in Clostridium difficile infections
Opioids should be stopped in Clostridium difficile infections
Ulcerative colitis: flares
MILD:
Fewer than — stools daily, with or without blood
No systemic disturbance
Normal— and – values
MODERATE
–stools a day, with minimal systemic disturbance
The Truelove and Witts’ severity index is recommended by NICE when assessing the severity of ulcerative colitis in adults.
Ulcerative colitis is classified as ‘severe’ when the patient has blood in their stool, or is passing more than – stools per day plus at least one of the following features:
THEA
Temperature greater than –°C
Heart rate greater than – beats per minute
Anaemia (Hb less than –g/ L)
Erythrocyte sedimentation rate greater than – mm/hour
Any patient with features of severe ulcerative colitis should be admitted to hospital as an emergency.
They should be treated with intravenous —to induce remission.
Mild:
Fewer than four stools daily, with or without blood
No systemic disturbance
Normal erythrocyte sedimentation rate and C-reactive protein values
MODERATE
Four to six stools a day, with minimal systemic disturbance
The Truelove and Witts’ severity index is recommended by NICE when assessing the severity of ulcerative colitis in adults. Ulcerative colitis is classified as ‘severe’ when the patient has blood in their stool, or is passing more than 6 stools per day plus at least one of the following features:
Temperature greater than 37.8°C
Heart rate greater than 90 beats per minute
Anaemia (Hb less than 105g/ L)
Erythrocyte sedimentation rate greater than 30 mm/hour
Any patient with features of severe ulcerative colitis should be admitted to hospital as an emergency. They should be treated with intravenous corticosteroids to induce remission.
The A–/A– ratio in alcoholic hepatitis is 2:1
The AST/ALT ratio in alcoholic hepatitis is 2:1